Summary
Overview
Work History
Education
Skills
Websites
Timeline
Generic

Eugene Wyatt

Chicago,IL

Summary

Effective communicator of biopharmaceutical information, with a background in translational research and clinical trials. Thoughtful creator of high-impact scientific and clinical content, with expertise in cardiology, genetics, and oncology. Insightful analyst who is able to distill complex data into a clear, patient-focused message tailored to audiences ranging from community healthcare professionals to high-level thought leaders.

Overview

18
18
years of professional experience

Work History

Clinical Project Lead

Monopar Therapeutics
Wilmette, IL
07.2022 - 03.2023
  • Facilitated scientific exchange with healthcare providers, as the primary liaison to 30 clinical sites engaged in a phase 2b/3 trial investigating a treatment for patients with oropharyngeal cancer.
  • Synthesized data from site communications into actionable insights for internal stakeholders, which impacted decisions on global clinical strategy.
  • Created clinical trial reports, educational slide decks, and a Frequently Asked Questions (FAQ) tool, in collaboration with a cross-functional operations team, ensuring site compliance.
  • Served as an educational resource for scientific and clinical information, responded to unsolicited queries, and maintained therapeutic area expertise in solid tumors.
  • Monitored the timely entry of accurate data, then developed and delivered site-specific training initiatives to resolve outstanding issues in collaboration with a contract research organization (CRO).

Project Manager

Northwestern University Transgenic Core
Chicago, IL
11.2018 - 06.2022
  • Served as project manager for an internal core facility and created preclinical gene edited models for prominent research and clinical investigator, receiving a promotion to Assistant Director (Jan 2022).
  • Led scientific client engagement, evaluated research proposals, developed design strategy, and drafted contracts that defined costs, timelines, limitations, and deliverables.
  • Analyzed gene editing data and provided investigators publication-ready project reports that included background information, method sections, and figures that supported their grant applications and publications.
  • Created and delivered customized seminars on gene editing to audiences with varied experience levels at departmental meetings and research conferences, through a faculty co-appointment.
  • Presented biannual reports to an internal advisory committee to showcase progress, define unmet needs, and discuss future directions which impacted the business strategy.

Postdoctoral Scholar

Northwestern University, Feinberg School of Medicine
Chicago , IL
09.2014 - 10.2018
  • Led translational studies and developed a novel gene therapy to treat a form of muscular dystrophy, and then provided scientific support to teams that secured a patent for the and an orphan drug designation from the US Food and Drug Administration (FDA).
  • Authored 3 peer-reviewed publications, promoted disease awareness through scientific presentations, and co-authored 2 invited commentaries on the clinical applications of emerging gene therapies.
  • Acquired insights from experts in gene therapy, drafted technical protocols, analyzed experimental data, interpreted the results, and provided a clear blueprint for future clinical studies.
  • Built partnerships with an international network of experts, established a pipeline for the processing of clinical samples, and authored a methods paper on the creation of human cell-based models of muscle disease.

Graduate Scholar

Northwestern University, Feinberg School of Medicine
Chicago, IL
09.2005 - 03.2012
  • Led preclinical studies that discovered a cardioprotective role for hexokinase (HK) oncogenes, at the intersection of cardiology and oncology, identifying HK2 as a pharmaceutical target for the treatment of heart disease.
  • Demonstrated treatment with the anti-tumor drug doxorubicin induced cardiomyocyte cell death that was associated with a reduction in HK2, and its mitochondrial localization.
  • Authored 3 high-impact, peer-reviewed publications, received a pre-doctoral grant from the American Heart Association (AHA), and presented at the AHA national meeting.

Education

Ph.D. - Cellular And Molecular Biology

Northwestern University
Evanston, IL
03-2012

Bachelor of Science - Neuroscience

University of Scranton
Scranton, PA
06-1999

Skills

  • Scientific and Medical Writing
  • Data Analysis and Interpretation
  • Project and Time Management
  • MS Office, PubMed, and Endnote
  • Client Engagement and Support
  • Oncology Clinical Trial Reports
  • Solid Tumor and Hematology
  • Cellular and Molecular Biology
  • Human Genetics and Rare Disease
  • Gene Editing Design and Analysis

Timeline

Clinical Project Lead

Monopar Therapeutics
07.2022 - 03.2023

Project Manager

Northwestern University Transgenic Core
11.2018 - 06.2022

Postdoctoral Scholar

Northwestern University, Feinberg School of Medicine
09.2014 - 10.2018

Graduate Scholar

Northwestern University, Feinberg School of Medicine
09.2005 - 03.2012

Ph.D. - Cellular And Molecular Biology

Northwestern University

Bachelor of Science - Neuroscience

University of Scranton

Similar Profiles

CREATE PROFILE
Eugene Wyatt